EchoPAC Software Only / EchoPAC Plug-in (v211)
GE Medical Systems Ultrasound and Primary Care Diagnostics · Decision date Sep 16, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on September 16, 2026 for K261623, EchoPAC Software Only / EchoPAC Plug-in (v211), submitted by GE Medical Systems Ultrasound and Primary Care Diagnostics under regulation 21 CFR 892.2050 with product codes QIH and LLZ, in the Radiology specialty. SESE is a 510(k) clearance to market, not a premarket approval. The FDA database lists the application as received May 15, 2026, a traditional submission not reviewed by a third party, with a Predetermined Change Control Plan authorized.
The submission describes software for diagnostic review and analysis of ultrasound images, patient record management and reporting, offered as software installed on customer PC hardware or as a plug-in hosted on a PACS workstation, with DICOM transfer over a LAN. The summary names EchoPAC Software Only / EchoPAC Plug-in (K251342) and Vivid E95 (K220882) as primary predicates and states the device uses the same fundamental scientific technology. The clearance letter's stated receipt date of August 18, 2026 conflicts with the database's May 15, 2026; the record does not resolve this.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Radiology
- Decision date
- Sep 16, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261623
- Regulatory pathway
- 510(k) premarket notification
- Product code
- QIH
- Decision code
- SESE
- Decision date
- Sep 16, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Automated Radiological Image Processing Software.
- Product code
- QIH
- FDA device class
- 2
FDA decision timeline
K261623 received
Application receipt date recorded by FDA.
K261623 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code QIH
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Clever OneK260372 | Ewoosoft Co., Ltd. | 510(k) clearance | Nov 4, 2026 | FDA |
PeekMed webK262667 | Peek Health, S.A. | 510(k) clearance | Nov 4, 2026 | FDA |
CINA-Aneurysm+K262147 | AVICENNA.AI | 510(k) clearance | Oct 19, 2026 | FDA |
Ligence HeartK261733 | UAB Ligence | 510(k) clearance | Oct 7, 2026 | FDA |
NeuroDRK262134 | Deep Reasoning Ai, Inc. | 510(k) clearance | Oct 7, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
GE Medical Systems Ultrasound and Primary Care Diagnostics
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Waukesha, WI
Sources and methodology
- Original FDA record: K261623
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


